Literature DB >> 30820838

Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.

Maria Carmela Padula1,2, Pietro Leccese3, Emanuela Pellizzieri2, Angela Anna Padula1, Michele Gilio1, Teresa Carbone1, Nancy Lascaro1, Giuseppina Tramontano1, Giuseppe Martelli2, Salvatore D'Angelo1,4.   

Abstract

The Endoplasmic reticulum aminopeptidase protein 1 (ERAP1) trims N-terminal amino acids from epitope precursors for Major Histocompatibility Complex class I presentation. Genome-wide association studies demonstrated that ERAP1 gene single nucleotide polymorphisms (SNPs) are associated with Behçet's syndrome (BS). This study was conducted on the two most consistently BS-associated ERAP1 polymorphisms, rs17482078 (NG_027839.1:g.35983G>A) and rs27044 (NG_027839.1:g.35997C>G) to analyse their distribution in 55 Italian BS patients and 65 ethnically matched controls (healthy controls, HC) and to test their association with BS risk. SNPs were detected by isolation, amplification of genomic DNA and direct sequencing. SNPs functional effects were predicted by bioinformatics software. The odds ratio (OR) with 95% confidence intervals was calculated to assess the strength of BS association for genotypes and alleles, also validated by logistic regression (LR). LR was used to test the association between both SNPs and patients HLA genetic data. Bonferroni correction was also applied. Comparing patients and controls, we found a significant higher frequency of rs17482078 A allele (32.73% BS vs 17.69% HC, p = 0.007) and AA genotype (18.18% BS vs 0% HC; p = 0.0003) and rs27044 G allele (63.64% BS vs 46.92% HC; p = 0.0096) in BS group after Bonferroni correction. No association was found between HLA-B*51 and both ERAP1 SNPs. Although preliminary, our data show a stronger association of rs17482078 with BS compared to rs27044 by means of case-control genetic analysis and bioinformatics prediction of protein structure change. A larger series of patients and controls is required to confirm our preliminary findings.

Entities:  

Keywords:  Behçet’s syndrome; Disease susceptibility; ERAP1; rs17482078; rs27044

Mesh:

Substances:

Year:  2019        PMID: 30820838     DOI: 10.1007/s11739-019-02056-w

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  16 in total

1.  Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians.

Authors:  Inês Sousa; Farhad Shahram; David Francisco; Fereydoun Davatchi; Bahar Sadeghi Abdollahi; Fahmida Ghaderibarmi; Abdolhadi Nadji; Niloofar Mojarad Shafiee; Joana M Xavier; Sofia A Oliveira
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

2.  HLA-Bw51 and Behçet's disease.

Authors:  S Ohno; T Asanuma; S Sugiura; A Wakisaka; M Aizawa; K Itakura
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

Review 3.  Behcet's syndrome in nonendemic regions.

Authors:  Pietro Leccese; Yusuf Yazici; Ignazio Olivieri
Journal:  Curr Opin Rheumatol       Date:  2017-01       Impact factor: 5.006

4.  Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity.

Authors:  Emma Reeves; Christopher J Edwards; Tim Elliott; Edward James
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

Review 5.  The immunogenetics of Behçet's disease: A comprehensive review.

Authors:  Masaki Takeuchi; Daniel L Kastner; Elaine F Remmers
Journal:  J Autoimmun       Date:  2015-09-05       Impact factor: 7.094

6.  A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.

Authors:  Masaki Takeuchi; Michael J Ombrello; Yohei Kirino; Burak Erer; Ilknur Tugal-Tutkun; Emire Seyahi; Yilmaz Özyazgan; Norman R Watts; Ahmet Gül; Daniel L Kastner; Elaine F Remmers
Journal:  Ann Rheum Dis       Date:  2016-05-23       Impact factor: 19.103

7.  Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.

Authors:  Joana M Xavier; Fereydoun Davatchi; Olga Abade; Farhad Shahram; Vânia Francisco; Bahar Sadeghi Abdollahi; Hélder Trindade; Abdolhadi Nadji; Niloofar Mojarad Shafiee; Fahmida Ghaderibarmi; Dário Ligeiro; Sofia A Oliveira
Journal:  Arthritis Res Ther       Date:  2015-03-19       Impact factor: 5.156

8.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.

Authors:  Yohei Kirino; George Bertsias; Yoshiaki Ishigatsubo; Nobuhisa Mizuki; Ilknur Tugal-Tutkun; Emire Seyahi; Yilmaz Ozyazgan; F Sevgi Sacli; Burak Erer; Hidetoshi Inoko; Zeliha Emrence; Atilla Cakar; Neslihan Abaci; Duran Ustek; Colleen Satorius; Atsuhisa Ueda; Mitsuhiro Takeno; Yoonhee Kim; Geryl M Wood; Michael J Ombrello; Akira Meguro; Ahmet Gül; Elaine F Remmers; Daniel L Kastner
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

9.  Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.

Authors:  Grazyna Kochan; Tobias Krojer; David Harvey; Roman Fischer; Liye Chen; Melanie Vollmar; Frank von Delft; Kathryn L Kavanagh; Matthew A Brown; Paul Bowness; Paul Wordsworth; Benedikt M Kessler; Udo Oppermann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

10.  Behçet's disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans.

Authors:  Eun Ha Kang; Sewon Kim; Min Young Park; Ji Yong Choi; In Ah Choi; Min Jung Kim; You-Jung Ha; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Changwon Kang; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2017-10-10       Impact factor: 5.156

View more
  3 in total

1.  A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study.

Authors:  Maria Carmela Padula; Pietro Leccese; Nancy Lascaro; Angela Anna Padula; Teresa Carbone; Giuseppe Martelli; Salvatore D'Angelo
Journal:  J Mol Neurosci       Date:  2020-11-20       Impact factor: 3.444

2.  Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Authors:  Giacomo Emmi; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

Review 3.  Experimental Therapeutic Solutions for Behcet's Disease.

Authors:  Burçin Cansu Bozca; Erkan Alpsoy
Journal:  J Exp Pharmacol       Date:  2021-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.